
    
      Clinical and laboratory characteristics related to the spleen in SCA patients will be
      studied.

      Two groups of patient will be compared, a group of Sickle cell patients (Homozygous) and a
      second group of patients with Sickle cell beta thalassemia.

      In those patients that splenectomy was performed the incidence of infections will be recorded
      besides the indications for splenectomy and the incidence of thrombotic events or
      thrombocytosis.
    
  